Amedisys/$AMED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Amedisys
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Ticker
$AMED
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
19,000
ISIN
US0234361089
Website
Amedisys Metrics
BasicAdvanced
$3.2B
36.06
$2.72
0.89
-
Price and volume
Market cap
$3.2B
Beta
0.89
52-week high
$98.95
52-week low
$82.15
Average daily volume
335K
Financial strength
Current ratio
1.288
Quick ratio
1.229
Long term debt to equity
31.21
Total debt to equity
36.304
Interest coverage (TTM)
7.48%
Profitability
EBITDA (TTM)
244.097
Gross margin (TTM)
43.37%
Net profit margin (TTM)
3.79%
Operating margin (TTM)
9.17%
Effective tax rate (TTM)
43.15%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
6.36%
Return on equity (TTM)
7.15%
Valuation
Price to earnings (TTM)
36.062
Price to revenue (TTM)
1.352
Price to book
2.68
Price to tangible book (TTM)
-34.02
Price to free cash flow (TTM)
14.668
Free cash flow yield (TTM)
6.82%
Free cash flow per share (TTM)
667.58%
Growth
Revenue change (TTM)
5.34%
Earnings per share change (TTM)
-530.21%
3-year revenue growth (CAGR)
2.19%
10-year revenue growth (CAGR)
7.11%
3-year earnings per share growth (CAGR)
-22.41%
10-year earnings per share growth (CAGR)
24.57%
What the Analysts think about Amedisys
Analyst ratings (Buy, Hold, Sell) for Amedisys stock.
Bulls say / Bears say
Amedisys reported adjusted earnings of $1.25 per share for Q1 2025, surpassing analyst expectations of $1.09, indicating strong financial performance. (tradingview.com)
The company has been recognized with 92 SHPBest™ Patient Satisfaction Awards in 2023, reflecting high patient satisfaction and quality of care. (stocktitan.net)
Amedisys' subsidiary, Contessa Health, was selected by CMS to participate in the GUIDE Model, potentially expanding its services and revenue streams. (stocktitan.net)
The U.S. Department of Justice filed a lawsuit to block UnitedHealth's $3.3 billion acquisition of Amedisys, citing concerns over reduced competition in the home health services market. (reuters.com)
Amedisys' net income for Q3 2024 decreased to $16.9 million from $26.0 million in the same quarter of 2023, indicating a decline in profitability. (stocktitan.net)
Analyst ratings have been downgraded, with Deutsche Bank lowering Amedisys to 'Hold' from 'Buy' and William Blair downgrading to 'Market Perform' from 'Outperform'. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Amedisys Financial Performance
Revenues and expenses
Amedisys Earnings Performance
Company profitability
Amedisys News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Amedisys stock?
Amedisys (AMED) has a market cap of $3.2B as of June 30, 2025.
What is the P/E ratio for Amedisys stock?
The price to earnings (P/E) ratio for Amedisys (AMED) stock is 36.06 as of June 30, 2025.
Does Amedisys stock pay dividends?
No, Amedisys (AMED) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Amedisys dividend payment date?
Amedisys (AMED) stock does not pay dividends to its shareholders.
What is the beta indicator for Amedisys?
Amedisys (AMED) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.